↓ Skip to main content

Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada

Overview of attention for article published in Pharmacoepidemiology & Drug Safety, April 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada
Published in
Pharmacoepidemiology & Drug Safety, April 2013
DOI 10.1002/pds.3442
Pubmed ID
Authors

Susan E. Tett, Ingrid Sketris, Charmaine Cooke, Sander Veldhuyzen van Zanten, Nadia Barozzi

Abstract

This study aimed to compare use of histamine H2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), 2001-2005, in the elderly and social security beneficiaries in Australia (AUS) and Nova Scotia, Canada (NS).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 32 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Student > Ph. D. Student 6 18%
Student > Master 4 12%
Student > Doctoral Student 3 9%
Student > Bachelor 3 9%
Other 5 15%
Unknown 6 18%
Readers by discipline Count As %
Medicine and Dentistry 12 36%
Pharmacology, Toxicology and Pharmaceutical Science 5 15%
Agricultural and Biological Sciences 2 6%
Computer Science 2 6%
Economics, Econometrics and Finance 1 3%
Other 0 0%
Unknown 11 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2013.
All research outputs
#20,739,552
of 25,477,125 outputs
Outputs from Pharmacoepidemiology & Drug Safety
#1,683
of 2,177 outputs
Outputs of similar age
#163,508
of 212,845 outputs
Outputs of similar age from Pharmacoepidemiology & Drug Safety
#17
of 27 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,177 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,845 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.